Log in
Enquire now
‌

US Patent 8633249 Adjuvant chemotherapy for anaplastic gliomas

Patent 8633249 was granted and assigned to Oklahoma Medical Research Foundation on January, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
86332490
Patent Inventor Names
Robert A. Floyd0
Rheal A. Towner0
Date of Patent
January 21, 2014
0
Patent Application Number
125527920
Date Filed
September 2, 2009
0
Patent Citations Received
‌
US Patent 11660280 Treatment of drug resistant gliomas
0
Patent Primary Examiner
‌
Samira Jean-Louis
0
Patent abstract

The present invention involves the use of 2,4-disulfonyl phenyl tert-butyl nitrone (2,4-ds-PBN) in the treatment and prevention of gliomas. The 2,4-ds-PBN may be used alone or combined with other traditional chemo- and radiotherapies and surgery, to treat or prevent glioma occurrence, recurrence, spread, growth, metastasis, or vascularization.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8633249 Adjuvant chemotherapy for anaplastic gliomas

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.